Workflow
FOCUSfactor
icon
Search documents
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
Globenewswire· 2026-01-27 13:00
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a major expansion of its FOCUSfactor® functional beverage portfolio across Canada, building on the successful launch of FOCUSfactor’s supplement SKUs at Walmart Canada and through McKesson Canada during Q4 2025, with sell-through and consumer feedback supporting category expansion. Beginning in April 2026, Walmart Canada will intro ...
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
Globenewswire· 2025-12-16 13:00
Core Insights - Synergy CHC Corp. has appointed Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America to enhance its international growth strategy [1][2] - The company has initiated product shipments to Costco Mexico, marking its entry into the Mexican market [2] - Colmenares brings over 18 years of experience in the pharmaceutical and consumer health sectors, which will be crucial for Synergy's expansion in Latin America [3][4] Company Strategy - The appointment of Colmenares is part of Synergy's strategy to build a scalable commercial foundation in Mexico and Latin America [2] - The company aims to drive growth in its supplement and functional beverage portfolios through effective market entry and expansion initiatives [2][3] - Synergy's flagship brand, FOCUSfactor, is positioned for growth in new markets, supported by established distribution channels [5] Leadership and Expertise - Pedro Colmenares has a proven track record in launching operations and developing distribution networks across Latin America [3][4] - His experience includes leadership roles at Procter & Gamble and Victus/Megalabs, where he successfully transformed underdeveloped markets into sustainable businesses [3][4] - Colmenares emphasizes the importance of building strong partnerships and executing localized strategies for sustainable growth [5]
Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability
Globenewswire· 2025-11-13 13:00
Core Insights - Synergy CHC Corp. reported its financial results for Q3 2025, marking its 11th consecutive quarter of profitability and achieving double-digit revenue growth alongside significant gross margin expansion [2][5]. Financial Performance - Revenue for Q3 2025 was $8.0 million, representing a 12.4% increase from $7.1 million in Q3 2024 [5][8]. - Gross margin improved to 70.9% in Q3 2025, up from 67.2% in Q3 2024, primarily due to a favorable product mix [5][8]. - Operating expenses rose to $4.4 million, a 17.7% increase compared to $3.7 million in Q3 2024, driven by costs associated with being a public company and launching the beverage division [6][8]. - Income from operations increased to $1.28 million, up 21.8% from $1.05 million in Q3 2024, attributed to improved gross margins [6][8]. - Net income for Q3 2025 was $125.3 thousand, down from $783.6 thousand in Q3 2024, with earnings per share at $0.01 compared to $0.11 in the prior year [7][8]. Business Developments - The company expanded its retail authorizations and distribution partnerships, notably with Kroger and Wakefern, enhancing its market reach across North America [2][8]. - A public offering completed in August 2025 raised $4.4 million, providing additional working capital for growth and brand expansion [2][8]. - Synergy appointed Teresa Thompson, a former Costco executive, to its Board of Directors, enhancing its expertise in retail and consumer health [8]. - FOCUSfactor was recognized as the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026 by Pharmacy Times, highlighting its market leadership [8]. Balance Sheet and Cash Flow - As of September 30, 2025, the company had approximately $1.0 million in cash and cash equivalents, up from $687.9 thousand at the end of 2024 [10][20]. - Working capital surplus increased to $16.68 million from a deficit of $1.12 million at the end of 2024 [10][20]. - Inventory stood at $2.1 million, compared to $1.7 million at the end of 2024 [10][20]. - Cash used in operating activities for the nine months ended September 30, 2025, was $3.21 million, compared to $1.38 million for the same period in 2024 [11][25].
Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
Globenewswire· 2025-11-05 13:00
Core Insights - Synergy CHC Corp. has announced a strategic distribution partnership with C&M Sales to enhance the availability of its FOCUSfactor® Focus + Energy products in Arkansas, capitalizing on the growing functional beverage market [1][4]. Company Overview - Synergy CHC Corp. specializes in consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line with a 25-year legacy, distributed in the U.S., Canada, and the U.K. through major retailers [5]. - Flat Tummy focuses on women's wellness and weight management, complementing Synergy's product portfolio [5]. Partnership Details - C&M Sales, a well-established beverage distributor in Arkansas with nearly 90 years of experience, will serve as Synergy's new Direct Store Delivery partner. The company has a strong reputation for brand-building and services over 3,500 accounts statewide [2][3]. - The partnership aims to leverage C&M Sales' long-standing relationships and expertise to expand FOCUSfactor's market presence in the functional beverage category [4]. Market Position - The non-alcohol division of C&M Sales, established in 2019, has quickly become a preferred distributor for non-alcoholic beverages in Arkansas, representing over 20 leading brands [3][6]. - The collaboration is expected to enhance the visibility and availability of FOCUSfactor products, driving innovation and consumer demand in the functional beverage sector [4].
Synergy CHC Corp. Announces Third Quarter 2025 Earnings and Conference Call Information
Globenewswire· 2025-10-30 20:05
Core Insights - Synergy CHC Corp. plans to release its financial results for Q3 2025 on November 13, 2025, before market trading [1] - A conference call will be held on the same day at 9:00 a.m. ET, featuring the CEO and CFO, with a live webcast available [2] Company Overview - Synergy CHC Corp. specializes in developing and marketing consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy [3] - FOCUSfactor is a clinically studied brain health supplement with a 25-year legacy, distributed in major retailers across the U.S., Canada, and the U.K., and is experiencing growth in new markets [3] - Flat Tummy is a lifestyle brand focused on women's wellness and weight management, complementing Synergy's product portfolio [3]
Synergy CHC Corp. (NASDAQ: SNYR) Announces FOCUSfactor® Named #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026
Globenewswire· 2025-10-27 12:00
Core Insights - FOCUSfactor has been recognized as the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026 according to the Pharmacy Times survey [1][2][3] - This recognition highlights the brand's commitment to brain-health science and consumer trust, reflecting the confidence pharmacists have in FOCUSfactor [3] Company Overview - Synergy CHC Corp. develops and markets consumer health and wellness products, with FOCUSfactor being a flagship brand known for clinically-studied formulations aimed at improving memory, focus, and cognitive clarity [3][5] - FOCUSfactor has over 20 years of category leadership and established distribution in the U.S., Canada, and the U.K. through major retailers such as Costco, Walmart, Amazon, BJ's, and Walgreens [5] - The brand is focused on expanding its brain-health and functional-wellness offerings across various channels, including pharmacy, mass retail, e-commerce, and international markets [3][5] Industry Context - Pharmacy Times serves as a leading resource for pharmacy professionals, providing insights and identifying trusted brands in key consumer health categories through its annual survey [6]
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
Globenewswire· 2025-10-22 12:00
Core Insights - Synergy CHC Corp. announced significant retail authorizations and distribution partnerships to expand its FOCUSfactor supplements and FOCUSfactor Focus + Energy beverages in the U.S., Canada, and international markets, responding to rising consumer demand for clean energy and cognitive health products [1][7]. U.S. Expansion - Kroger will launch three FOCUSfactor SKUs across 1,600 locations starting April 2026, enhancing FOCUSfactor's position as a leader in cognitive health supplements [2]. - Wakefern Food Corp. will introduce five FOCUSfactor Focus + Energy SKUs in 365 retail locations, furthering Synergy's national beverage rollout strategy [3]. Canadian Expansion - Uniprix will launch FOCUSfactor supplement SKUs in 300 stores beginning February 2026, while Fortinos will debut FOCUSfactor Focus + Energy beverages in 24 locations [4]. - Pilot Flying J will carry FOCUSfactor beverages across 56 travel centers, marking a significant milestone in Synergy's retail expansion in Canada [5]. International Expansion - PriceSmart will launch FOCUSfactor Focus + Energy 12-pack across 47 clubs in 13 countries, reaching over 3 million members, thus introducing FOCUSfactor beverages to new markets in Latin America and the Caribbean [6]. Strategic Partnerships - The partnerships with major retailers like Kroger, Wakefern, and PriceSmart validate Synergy's global scaling strategy and commitment to delivering clean energy and brain health solutions [7].
Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
Globenewswire· 2025-08-27 20:15
Group 1 - Synergy CHC Corp. closed an underwritten public offering of 1,750,000 shares at a price of $2.50 per share, raising gross proceeds of $4.375 million before expenses [1] - The company granted underwriters a 45-day option to purchase an additional 262,500 shares at the public offering price [1] - The underwriter received warrants to purchase up to 52,500 shares, which can increase to 60,375 if the over-allotment is exercised, with specific expiration tranches [2] Group 2 - Bancroft Capital, LLC served as the sole book-running manager for the offering, with legal representation from Lucosky Brookman LLP [3] - Synergy CHC Corp. is known for its consumer health and wellness products, including flagship brands FOCUSfactor and Flat Tummy, with established distribution in major retailers [6] - FOCUSfactor is a clinically studied brain health supplement with a 25-year legacy, and the brand is expanding into new markets [6]
Synergy CHC Corp to Present at the 2025 Gateway Conference on September 4th
Globenewswire· 2025-08-21 12:00
Company Overview - Synergy CHC Corp. is a leading consumer health and wellness company known for its flagship brands FOCUSfactor and Flat Tummy [6] - FOCUSfactor is a clinically studied brain health supplement with a 25-year legacy, distributed in the U.S., Canada, and the U.K. through major retailers like Costco, Walmart, Amazon, BJ's, and Walgreens [6] - The company is experiencing growth by penetrating new markets and has secured recent retail wins across various channels, which are expected to drive gains in late 2025 [6] Conference Participation - Synergy is confirmed to present at the 2025 Annual Gateway Conference on September 4 at 9:30 a.m. Pacific Time [1][2] - The presentation will be webcast live, and Synergy executives will be available for one-on-one meetings throughout the conference [2] Gateway Conference Details - The Gateway Conference connects growth-stage companies with prospective investors, analysts, and partners [3] - Attendees will have access to presentations and one-on-one meetings with senior executives from over 75 private and public companies across various sectors [4]
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
Globenewswire· 2025-08-14 12:00
Core Insights - Synergy CHC Corp. reported strong financial results for Q2 2025, marking its tenth consecutive quarter of profitability, with year-over-year growth in revenue, gross profit, net income, and earnings per share [2][5][7] Financial Performance - Revenue for Q2 2025 was $8.1 million, a 1% increase from $8.0 million in Q2 2024 [5][8] - Gross margin improved to 76.7% in Q2 2025 from 69.5% in Q2 2024, primarily due to increased license revenue [5][8] - Operating expenses rose to $4.6 million, up 16% from $4.0 million in Q2 2024, attributed to costs related to being a public company [6][8] - Income from operations was $1.62 million, a 2.5% increase compared to $1.58 million in Q2 2024 [6][8] - Net income surged to $1.5 million, reflecting a 125% increase from $655.2 thousand in Q2 2024 [7][8] - Earnings per share increased to $0.17, up 86% from $0.09 in Q2 2024 [7][8] - EBITDA for Q2 2025 was $3.80 million, a 136% increase from $1.61 million in Q2 2024 [9] Strategic Developments - The company expanded its FOCUSfactor brand's global presence through a licensing agreement in Turkey [2][8] - Synergy secured distribution partners across North America for its ready-to-drink (RTD) beverage business [2][8] - A $20 million debt refinancing was completed, enhancing financial flexibility and supporting long-term growth strategies [2][8] Balance Sheet and Cash Flow - As of June 30, 2025, cash and cash equivalents increased to approximately $1.5 million from $687.9 thousand at the end of 2024 [10][20] - Working capital surplus improved to $12.4 million from a deficit of $1.12 million at the end of 2024 [10][20] - Inventory rose to $2.4 million from $1.7 million at the end of 2024 [10][20] - Cash used in operating activities for the first half of 2025 was $899.7 thousand, an improvement from $1.1 million in the same period of 2024 [11][27]